These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2465940)

  • 1. High risk malignant gestational trophoblastic disease: experience with triple chemotherapy (MAC) in Third World circumstances.
    du Toit JP
    Gynecol Oncol; 1989 Mar; 32(3):310-3. PubMed ID: 2465940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor prognosis metastatic gestational trophoblastic disease: experience with moderate dose methotrexate plus folinic acid rescue as initial therapy.
    Gerulath AH; Dembo AJ; Aitken S; Quirt IC; Osborne R; Blackstein M; Rider WD
    Gynecol Oncol; 1986 Nov; 25(3):294-301. PubMed ID: 3023204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic disease.
    Hammond CB; Olt GJ
    Curr Ther Endocrinol Metab; 1994; 5():567-70. PubMed ID: 7704794
    [No Abstract]   [Full Text] [Related]  

  • 5. Mono and polichemotherapy in the treatment of metastatic and invasive gestational trophoblastic disease: analysis of 50 cases.
    de Andrade JM; Murta EF; de Freitas MM; Pires CR; Bighetti S
    Rev Paul Med; 1993; 111(6):433-8. PubMed ID: 7519787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver metastases of gestational trophoblastic tumor.
    Bakri YN; Subhi J; Amer M; Ezzat A; Sinner W; Tweijry A; Jabbar FA
    Gynecol Oncol; 1993 Jan; 48(1):110-3. PubMed ID: 8380786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT--25 years experiences of KRI-TRD.
    Kim SJ; Bae SN; Kim JH; Kim CT; Han KT; Lee JM; Jung JK
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S85-96. PubMed ID: 9833620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management of low-risk metastatic gestational trophoblastic disease.
    Jones WB
    J Reprod Med; 1987 Sep; 32(9):653-6. PubMed ID: 2822918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of metastatic gestational trophoblastic neoplasms. A brief review of developments in the years 1968 to 1978.
    Lewis JL
    Am J Obstet Gynecol; 1980 Jan; 136(2):163-72. PubMed ID: 6243444
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy for trophoblastic disease: current standards.
    Kendall A; Gillmore R; Newlands E
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):33-8. PubMed ID: 11801874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of gestational trophoblastic disease at a single institute.
    Alici S; Eralp Y; Saip P; Argon A; Basaran M; Topuz E; Aydiner A
    Tohoku J Exp Med; 2002 Jun; 197(2):95-100. PubMed ID: 12233789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Cancer; 1982 Nov; 50(10):2024-7. PubMed ID: 6290020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of methotrexate in the chemotherapy of gestational trophoblastic neoplasms.
    Sobrero A; Bertino JR
    Adv Exp Med Biol; 1984; 176():343-54. PubMed ID: 6093467
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified Bagshawe's regimen in high-risk gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Gynecol Oncol; 1986 Jan; 23(1):87-93. PubMed ID: 3002917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.